Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma

被引：0
|
作者：
Prakash Ambady
Rongwei Fu
Laszlo Szidonya
David M. Peereboom
Nancy D. Doolittle
Edward A. Neuwelt
机构：
[1] Oregon Health & Science University,Department of Neurology
[2] Oregon Health & Science University,School of Public Health, Department of Clinical Epidemiology and Medical Informatics
[3] Cleveland Clinic,Burkhardt Brain Tumor Center
[4] Oregon Health & Science University,Department of Neurosurgery
[5] Portland Veterans Affairs Medical Center,undefined
来源：
Journal of Neuro-Oncology | 2020年 / 147卷
关键词：
Primary CNS lymphoma; Maintenance therapy; Rituximab; High-dose methotrexate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 176
页数：5
相关论文
共 50 条
  • [1] Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma
    Ambady, Prakash
    Fu, Rongwei
    Szidonya, Laszlo
    Peereboom, David M.
    Doolittle, Nancy D.
    Neuwelt, Edward A.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (01) : 171 - 176
  • [2] MAINTENANCE THERAPY USING RITUXIMAB FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Ichikawa, Tomotsugu
    Kurozumi, Kazuhiko
    Date, Isao
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 970 - 970
  • [3] MAINTENANCE THERAPY USING RITUXIMAB FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Ichikawa, T.
    Kambara, H.
    Kosaka, H.
    Inoue, S.
    Yoshida, K.
    Onishi, M.
    Date, I.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1085 - 1085
  • [4] Rituximab maintenance therapy in central nervous system lymphoma?
    Murawski, Niels
    Pfreundschuh, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2009, 50 (10) : 1555 - 1556
  • [5] Maintenance therapy for central nervous system lymphoma with rituximab
    Ney, Douglas E.
    Abrey, Lauren E.
    [J]. LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1548 - 1551
  • [6] The Role of Rituximab in Primary Central Nervous System Lymphoma
    Jacoline E. C. Bromberg
    Matthijs van der Meulen
    Jeanette K. Doorduijn
    [J]. Current Oncology Reports, 2020, 22
  • [7] The Role of Rituximab in Primary Central Nervous System Lymphoma
    Bromberg, Jacoline E. C.
    van der Meulen, Matthijs
    Doorduijn, Jeanette K.
    [J]. CURRENT ONCOLOGY REPORTS, 2020, 22 (08)
  • [8] The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
    Van Dijck, Ruben
    Doorduijn, Jeanette K.
    Bromberg, Jacoline E. C.
    [J]. CANCERS, 2021, 13 (08)
  • [9] Rituximab monotherapy for relapsed or refractory primary central nervous system lymphoma
    Batchelor, T. T.
    Lesser, G. J.
    Grossman, S. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] IMPACT OF ADDITIONAL RITUXIMAB TO STANDARD THERAPY ON COGNITIVE PERFORMANCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS
    van der Meulen, Matthijs
    Dirven, Linda
    Habets, Esther
    Bakunina, Katerina
    Taphoorn, Martin
    van den Bent, Martin
    Issa, Samar
    Doorduijn, Jeanette K.
    Bromberg, Jacoline E. C.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 159 - 159
12345